Discover 322 paid clinical trials in New Mexico. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
New Mexico provides a wide selection of paid research opportunities for both healthy volunteers and individuals with specific health conditions. Leading research sites in Albuquerque, Santa Fe, and Las Cruces are actively recruiting, offering early access to innovative treatments and exceptional healthcare.
Filter
1
Filter results
Results: 322
De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information
for
Epilepsy, Status Epilepticus, Seizures
Location: Albuquerque NM
Sponsor: University of New Mexico
Sex: All
Age: 18+
Code: NCT05140265
Recruiting
Outcomes of Clareon PanOptix Pro in Patients With Prior Myopic Refractive Surgery
for
Cataract
Location: Albuquerque NM
Sponsor: Juliette Eye Institute Research Center
Sex: All
Age: 45+
Code: NCT06555289
Recruiting
The Effect of Hand Exercises on Upper Limb Volume, Quality of Life, and Hand Function in Breast Cancer Survivors
for
Breast Cancer Lymphedema
Location: Santa Fe NM, Albuquerque NM, Rio Rancho NM
Sponsor: Texas Woman's University
Sex: Female
Age: 18+
Code: NCT05983380
Recruiting
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
A Pilot Study of Non-invasive Brain Stimulation to Boost the Efficacy of Psychotherapy in a Community Sample of People Who Drink Alcohol
for
Alcohol Use Disorder
Location: Albuquerque NM
Sponsor: The Mind Research Network
Sex: All
Age: 21 - 60
Code: NCT04770025
Phase2, Recruiting
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
for
Multiple Myeloma
Location: Providence RI, Farmington CT, New Haven CT, Lebanon NH,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05552222
Phase3, Recruiting
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Halifax, Scarborough ME, Boston MA, Providence RI,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT06401330
Phase3, Recruiting
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
for
Type 2 Diabetes
Location: New Haven CT, Hyde Park NY, Philadelphia PA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 10 - 17
Code: NCT06739122
Phase3, Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Location: Boston MA, Manhasset NY, New York NY, Philadelphia PA,
Sponsor: Neuron23 Inc.
Sex: All
Age: 40 - 70+
Code: NCT06680830
Phase2, Recruiting
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
for
Metastatic Digestive System Neuroendocrine Tumor G1,
Location: Ottawa, North Miami FL, Aventura FL, Deerfield Beach FL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05773274
Phase2, Recruiting
Suicide in Urban Natives: Detection and Networks to Combat Events
for
Suicide Prevention
Location: Albuquerque NM
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 34
Code: NCT03136094
Recruiting
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
for
End-Stage Kidney Disease, End-Stage Renal Disease
Location: Gainesville FL, Decatur GA, Iowa City IA,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT05931276
Phase3, Recruiting
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
for
Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer,
Location: Boston MA, Commack NY, Baltimore MD, Ottawa, Toronto,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05123482
Phase1, Phase2, Recruiting
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
for
Head and Neck Squamous Cell Carcinoma
Location: St. John's, Hackensack NJ, Philadelphia PA, Norfolk VA,
Sponsor: Merus B.V.
Sex: All
Age: 18+
Code: NCT06525220
Phase3, Recruiting
Uterine Preservation Via Lifestyle Transformation
for
Endometrial Hyperplasia, Grade 1 Endometrial Cancer
Location: St Louis MO, Oklahoma City OK, Albuquerque NM
Sponsor: Washington University School of Medicine
Sex: Female
Age: 18+
Code: NCT05903131
Phase2, Recruiting
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Carcinoma, Non-Small-Cell Lung
Location: Boston MA, Shirley NY, New Haven CT, Lebanon NH,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06667076
Phase2, Recruiting
Clinical Evaluation of Precision for the Potassium and Ionized Calcium Tests in Capillary Specimens